JP2012025783A5 - - Google Patents

Download PDF

Info

Publication number
JP2012025783A5
JP2012025783A5 JP2011244902A JP2011244902A JP2012025783A5 JP 2012025783 A5 JP2012025783 A5 JP 2012025783A5 JP 2011244902 A JP2011244902 A JP 2011244902A JP 2011244902 A JP2011244902 A JP 2011244902A JP 2012025783 A5 JP2012025783 A5 JP 2012025783A5
Authority
JP
Japan
Prior art keywords
group
potassium
polymer
combination
combination according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011244902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012025783A (ja
JP5600658B2 (ja
Filing date
Publication date
Priority claimed from US10/814,527 external-priority patent/US7854924B2/en
Priority claimed from US10/813,872 external-priority patent/US8282960B2/en
Priority claimed from US10/814,749 external-priority patent/US8192758B2/en
Application filed filed Critical
Publication of JP2012025783A publication Critical patent/JP2012025783A/ja
Publication of JP2012025783A5 publication Critical patent/JP2012025783A5/ja
Application granted granted Critical
Publication of JP5600658B2 publication Critical patent/JP5600658B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011244902A 2004-03-30 2011-11-08 イオン結合ポリマーとその利用 Expired - Lifetime JP5600658B2 (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US10/814,527 US7854924B2 (en) 2004-03-30 2004-03-30 Methods and compositions for treatment of ion imbalances
US10/813,872 US8282960B2 (en) 2004-03-30 2004-03-30 Ion binding compositions
US10/814,749 US8192758B2 (en) 2004-03-30 2004-03-30 Ion binding compositions
US10/813,872 2004-03-30
US10/814,527 2004-03-30
US10/814,749 2004-03-30
US10/965,274 2004-10-13
US10/965,274 US7488495B2 (en) 2004-03-30 2004-10-13 Ion binding polymers and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007506580A Division JP4974882B2 (ja) 2004-03-30 2005-03-30 イオン結合ポリマーとその利用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012240298A Division JP5671511B2 (ja) 2004-03-30 2012-10-31 イオン結合ポリマーとその利用

Publications (3)

Publication Number Publication Date
JP2012025783A JP2012025783A (ja) 2012-02-09
JP2012025783A5 true JP2012025783A5 (https=) 2012-12-27
JP5600658B2 JP5600658B2 (ja) 2014-10-01

Family

ID=40774830

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011244902A Expired - Lifetime JP5600658B2 (ja) 2004-03-30 2011-11-08 イオン結合ポリマーとその利用
JP2011246755A Expired - Fee Related JP5431439B2 (ja) 2004-03-30 2011-11-10 イオン結合組成物
JP2012240298A Expired - Lifetime JP5671511B2 (ja) 2004-03-30 2012-10-31 イオン結合ポリマーとその利用
JP2013246976A Withdrawn JP2014040484A (ja) 2004-03-30 2013-11-29 イオン結合ポリマーとその利用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2011246755A Expired - Fee Related JP5431439B2 (ja) 2004-03-30 2011-11-10 イオン結合組成物
JP2012240298A Expired - Lifetime JP5671511B2 (ja) 2004-03-30 2012-10-31 イオン結合ポリマーとその利用
JP2013246976A Withdrawn JP2014040484A (ja) 2004-03-30 2013-11-29 イオン結合ポリマーとその利用

Country Status (13)

Country Link
EP (6) EP2184059B1 (https=)
JP (4) JP5600658B2 (https=)
KR (5) KR20130086262A (https=)
CN (2) CN102133196B (https=)
AT (2) ATE460927T1 (https=)
AU (5) AU2010214729B2 (https=)
CA (2) CA2806465C (https=)
DE (4) DE112005000708B4 (https=)
DK (2) DK3219312T3 (https=)
ES (6) ES2388052T3 (https=)
GB (2) GB2456253B (https=)
PL (3) PL2184059T3 (https=)
PT (3) PT2184059E (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9795755B2 (en) 2012-07-11 2017-10-24 Koninklijke Philips N.V. Patient interface
TW201628631A (zh) * 2014-12-23 2016-08-16 亞德利克斯公司 用於治療高血鉀症之組合物及方法
CN112291678B (zh) * 2020-04-03 2023-11-21 南京西觉硕信息科技有限公司 一种音频设备
US20240139234A1 (en) * 2021-11-17 2024-05-02 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Pharmaceutical polymer for treating hyperkalemia and preparation method thereof
CN117106852B (zh) * 2023-09-04 2024-03-19 济宁市兖州区检验检测中心 一种快速检测农产品农药残留的检测方法及其应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3031737A1 (de) 1980-08-22 1982-04-01 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von perlpolymerisaten einheitlicher teilchengroesse
US4675140A (en) 1984-05-18 1987-06-23 Washington University Technology Associates Method for coating particles or liquid droplets
CN1010098B (zh) * 1985-05-25 1990-10-24 赫彻斯特股份公司 α-氟代丙烯酸酯聚合物的制备方法
US4837015A (en) * 1987-03-05 1989-06-06 Carolina Medical Products Company, Inc. Alkali metal ion-charged, cation exchanger and use thereof to adjust sodium, potassium and calcium body fluid levels
FR2634377B1 (fr) * 1988-06-30 1991-09-27 Cortial Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
GB8829088D0 (en) 1988-12-13 1989-01-25 Smith Kline French Lab Compounds
US5236701A (en) 1989-07-19 1993-08-17 Lowchol Scientific Inc. Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
DE3928990A1 (de) 1989-09-01 1991-03-07 Bayer Ag Verfahren zur herstellung von (alpha)-fluoroacrylsaeurederivaten
US5112993A (en) 1989-11-14 1992-05-12 E. I. Du Pont De Nemours And Company Process for the preparation of difluoromaleic anhydride
ES2070307T3 (es) * 1990-07-04 1995-06-01 Marcin Krotkiewski Una preparacion para el tratamiento de la hipertension.
DE4139747A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Fuellstoffhaltige, optisch aktive perlpolymerisate
AU692432B2 (en) 1993-02-17 1998-06-11 British Technology Group Limited Polymeric compounds
WO1994027619A1 (en) * 1993-05-20 1994-12-08 Geltex Pharmaceuticals, Inc. Process for adjusting ion concentration in a patient and compositions therefor
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JPH09506342A (ja) * 1993-11-25 1997-06-24 サルテルナテ・ベー・ブイ 一価カチオンに結合する粒子、並びにナトリウムおよび／またはカリウムイオンを捕捉して除去するための上記粒子の使用および方法
WO1996021454A1 (en) 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
GB9503061D0 (en) 1995-02-16 1995-04-05 British Tech Group Polymeric compounds
ES2162658T3 (es) 1996-03-05 2002-01-01 Mitsubishi Chem Corp Utilizacion de resinas intercambiadoras anionicas para la fabricacion de un medicamento destinado al tratamiento de la hiperfosfatemia.
WO1997049387A1 (en) * 1996-06-27 1997-12-31 G.D. Searle And Co. Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
EP0922461A4 (en) * 1996-07-19 2002-07-17 Nikken Chemicals Co Ltd MEDICINE AGAINST HYPERPHOSPHATANEMIA
EP0934352B1 (en) 1996-10-23 2007-05-02 Dow Global Technologies Inc. Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
WO1998042355A1 (en) 1997-03-25 1998-10-01 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers combined with a calcium supplement for oral administration
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
CA2315088A1 (en) 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
US6294163B1 (en) 1998-10-02 2001-09-25 Geltex Pharmaceuticals, Inc. Polymers containing guanidinium groups as bile acid sequestrants
AU1998200A (en) * 1999-01-07 2000-07-24 Elan Corporation, Plc Multiparticulate oral dosage forms
WO2001002452A1 (en) 1999-07-02 2001-01-11 Symyx Technologies, Inc. Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded thereto
KR20020026366A (ko) 1999-08-09 2002-04-09 한스 루돌프 하우스, 헨리에데 부르너 단백질의 생산
KR100794427B1 (ko) 1999-10-19 2008-01-16 젠자임 코포레이션 직접 압축형 중합체 정제 코어
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
AU2002232955A1 (en) 2000-11-20 2002-05-27 Dow Global Technologies Inc. In vivo use of water absorbent polymers
AU2002252632B2 (en) 2001-04-18 2004-09-23 Genzyme Corporation Low salt forms of polyallylamine
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
BRPI0509331B8 (pt) * 2004-03-30 2021-05-25 Ilypsa Inc uso de uma composição de ligação de sódio

Similar Documents

Publication Publication Date Title
JP2007531774A5 (https=)
JP2012025783A5 (https=)
JP2014521735A5 (https=)
JP2012502015A5 (https=)
Wallace et al. Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis
JP2012532874A5 (https=)
RU2005135016A (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
BR0313469A (pt) Forma galêmica para a liberação cólica de princìpios ativos
JP2014515351A5 (https=)
JP2015522603A5 (https=)
DK1326595T3 (da) Administration af resveratrol til at behandle inflammatoriske respiratoriske lidelser
JP2013056909A5 (https=)
WO2009100181A3 (en) Absorbent ingestible agents and associated methods of manufacture and use
RU2010153904A (ru) Ниацин-содержащие композиции с модифицированным высвобождением
JP2009541348A5 (https=)
JP2020510000A5 (https=)
JP2010506991A5 (https=)
JP2009256374A5 (https=)
BR112015019180A2 (pt) ácidos tetrahidrocanabinol-11-óico ultrapuros
JP2006516272A5 (https=)
JP2015515968A5 (https=)
RU2009139260A (ru) Таблетка с улучшенной стабильностью, содержащая по меньшей мере два активных компонента
JP2016535780A5 (https=)
JP2011513304A5 (https=)
JP2015516419A5 (https=)